Jorveza 1 mg
Jorveza 1 mg is a medicine authorised by Swissmedic under authorisation number 66999. The authorisation holder is Dr. Falk Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 May 2018 and the authorisation is valid without a time limit. ATC code A07EA06 places the medicine in the group Antidiarrheals, intestinal anti-inflammatory and anti-infective agents.
| Authorisation number | 66999 |
|---|---|
| Name | Jorveza 1 mg |
| Full name | Jorveza 1 mg, Schmelztabletten |
| Authorisation holder | Dr. Falk Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A07EA06 |
| First authorisation | 25 May 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Jorveza 1 mg, Schmelztabletten | B | 25 May 2018 |
| 2 | Jorveza 0.5 mg, Schmelztabletten | B | 15 April 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | A07EA06 | 04.99.0. | B |
| 2 | 60 | Tablette(n) | A07EA06 | 04.99.0. | B |
| 6 | 90 | Tablette(n) | A07EA06 | 04.99.0. | B |
| 3 | 20 | Tablette(n) | A07EA06 | 04.99.0. | B |
| 5 | 90 | Tablette(n) | A07EA06 | 04.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Jorveza 1 mg authorised in Switzerland?
Yes. Jorveza 1 mg is authorised by Swissmedic under authorisation number 66999, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Jorveza 1 mg have?
Jorveza 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Jorveza 1 mg?
The authorisation holder is Dr. Falk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.